Valuation : BOIRON

Market Cap 44Cr 52Cr 42Cr 38Cr 71Cr 4.88TCr 72Cr 494.16Cr 191.76Cr 2.5TCr 193.96Cr 189.73Cr 8.06TCr P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 40Cr 46Cr 37Cr 34Cr 64Cr 4.35TCr 64Cr 440.96Cr 171.11Cr 2.23TCr 173.08Cr 169.3Cr 7.19TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+1.56%
1 week+2.77%
Current month+1.96%
1 month-6.47%
3 months-8.13%
6 months-1.52%
Current year-14.19%
1 week 25.3
Extreme 25.3
26.2
1 month 25
Extreme 25
27.8
Current year 24.35
Extreme 24.35
30.95
1 year 22
Extreme 22
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/23 Sell

Director

1,98,664 1.1323%
29/10/23 Sell

Director

4,62,964 2.6387%
29/10/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+2.77%+18.18%-50.38% 52Cr
+0.49%+2.06%-14.15%-6.49% 1.35TCr
+1.17%-0.86%-31.77%-56.34% 486.98Cr
+2.06%-0.90%-1.42%-3.27% 451.8Cr
+0.95%-2.34%-4.17%-31.12% 390.85Cr
-0.06%-1.21%-20.50%+1.67% 356.66Cr
+0.82%+2.06%+0.19%-1.76% 350.17Cr
+0.34%-0.61%-9.69%+5.29% 326.38Cr
0.00%-4.26%-22.13%-14.85% 233.05Cr
-0.20%-1.97%-26.78%-17.22% 168.22Cr
Average +0.71%+0.15%-11.22%-17.45% 416.39Cr
Weighted average by Cap. +0.71%+0.59%-13.44%-13.71%

Financials

2024 2025
Net sales 49Cr 57Cr 46Cr 42Cr 78Cr 5.35TCr 79Cr 542.06Cr 210.34Cr 2.74TCr 212.76Cr 208.12Cr 8.84TCr 50Cr 58Cr 47Cr 43Cr 81Cr 5.5TCr 81Cr 557.12Cr 216.19Cr 2.82TCr 218.68Cr 213.91Cr 9.09TCr
Net income 1.13Cr 1.32Cr 1.07Cr 97.43L 1.82Cr 124.38Cr 1.83Cr 13Cr 4.89Cr 64Cr 4.95Cr 4.84Cr 205.59Cr 3.26Cr 3.79Cr 3.07Cr 2.81Cr 5.25Cr 358.17Cr 5.26Cr 36Cr 14Cr 183.76Cr 14Cr 14Cr 592Cr
Net Debt -4.97Cr -5.78Cr -4.68Cr -4.27Cr -8Cr -545.74Cr -8.02Cr -55Cr -21Cr -280Cr -22Cr -21Cr -902.03Cr -4.79Cr -5.56Cr -4.5Cr -4.11Cr -7.69Cr -525.07Cr -7.72Cr -53Cr -21Cr -269.4Cr -21Cr -20Cr -867.88Cr
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
04/26/04 26.00 +1.56% 1,850
03/26/03 €25.60 -2.29% 2,665
02/26/02 €26.20 +1.95% 375
01/26/01 €25.70 +0.78% 487
31/26/31 €25.50 +0.79% 1,545

Annual profits - Rate of surprise